Thomson Reuters has introduced Cortellis for Competitive Intelligence, a product that the company says brings the best of the pharmaceutical data sources owned by Thomson Reuters into a single, intuitive solution.
Designed with users’ needs in mind, Cortellis for Competitive Intelligence is a life sciences intelligence tool that delivers critical information when you need it most. From drug discovery data to patent reports, Cortellis for Competitive Intelligence can give users the confidence to make the best decisions for their organisation, faster.
The company says Cortellis for Competitive Intelligence saves time and resources through:
- Superior analytics – easy-to-use analytics and visualisations to quickly interrogate data;
- Trusted content – extensive pharmaceutical content, collated by industry experts, combined with commentary from the Thomson Reuters global team of scientific editors;
- An intuitive interface allowing users to find the exact data they want, faster, with advanced searching techniques; and
- The ability to access Cortellis whenever and wherever users want, and the ability to easily share results with agile export and reporting tools.